外体非编码RNAs:在冠状动脉疾病的诊断和治疗中的关键分子
Cuixue Ma1,2, Xinyu Gao1,2, Kongwei Li1,2
1Guangdong Provincial Engineering Technology Research Center for Molecular Diagnosis and Innovative Drugs Translation of Cardiopulmonary Vascular Diseases, University Joint Laboratory of Guangdong Province and Macao Region on Molecular Targets and Intervene, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
PeerJ
|June 16, 2025
概括
需要新的生物标志物来诊断冠状动脉疾病 (CAD). 外体非编码RNA显示为CAD的独特指标,有助于诊断和预后.
科学领域:
- 心血管医学 心血管医学
- 分子生物学分子生物学
- 生物标志物发现发现
背景情况:
- 冠状动脉疾病 (CAD) 是一个主要的全球健康问题,由于人口老龄化和生活方式的变化,发病率越来越高.
- 目前的CAD生物标志物 (例如CK-MB,热素,NT-proBNP) 缺乏特异性,并受到各种生理因素的影响.
- 对于准确的CAD诊断和预后,需要独特可靠的生物标志物至关重要.
研究的目的:
- 审查目前对CAD的理解.
- 强调外体非编码RNAs作为CAD潜在的新生物标志物的作用.
- 讨论它们在CAD诊断和治疗中的意义.
主要方法:
- 文献综述专注于CAD的病变发生.
- 对研究心血管疾病中的外体非编码RNA的研究进行分析.
- 对外体非编码RNA作为诊断和预后标记物的当前知识的综合.
主要成果:
- 外体含有非编码RNA,蛋白质和脂质,在生物过程中起到关键的调节作用.
- 外体非编码RNA已被确定为CAD的风险因素和关键参与者.
- 这些分子显示出作为CAD诊断和预后的特定生物标志物的潜力.
结论:
- 外体非编码RNA代表了开发冠状动脉疾病新型特异生物标志物的有希望的途径.
- 它们在CAD病变发生中的作用和作为诊断/预后工具的潜力需要进一步研究.
- 未来的研究应该专注于验证这些外体非编码RNA在CAD管理中的临床应用.
相关概念视频
01:36Overview of Exosomes
2.9K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.9K
01:30Coronary Artery Disease I: Introduction
69
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
69
02:39lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
01:26Coronary Artery Disease II: Pathophysiology
44
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
44
01:26Coronary Artery Disease IV: Preventive Measures
40
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
40
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
226
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
226